Dubai's Medcare Hospital Becomes the World's First to Treat an Adult Spinal Muscular Atrophy (SMA) Patient Outside the US

Dubai's Medcare Hospital Becomes the World's First to Treat an Adult Spinal Muscular Atrophy (SMA) Patient Outside the US

DUBAI, United Arab Emirates -- Medcare Royal Speciality Hospital (MRSH) in Dubai has become the world’s first hospital outside the USA, to offer a newly licensed intrathecal gene therapy - Itvisma, to adult patients with Spinal Muscular Atrophy (SMA). This one-time treatment was recently administered to a 22-year-old Egyptian patient, who was diagnosed at 18 months and confined to a wheelchair for most of his life.

Dubai’s Medcare Hospital Becomes the World’s First to Treat an Adult Spinal Muscular Atrophy (SMA) Patient Outside the US - Global News Network Liberia

Medcare Royal Speciality Hospital (MRSH) in Dubai has become the world’s first hospital outside the USA, to offer a newly licensed intrathecal gene therapy – Itvisma, to adult patients with Spinal Muscular Atrophy (SMA). This one-time treatment was recently administered to a 22-year-old Egyptian patient, who was diagnosed at 18 months and confined to a wheelchair for most of his life. Last year, Medcare also became the first healthcare provider …

Dubai’s Medcare Hospital becomes world’s first to treat adult Spinal Muscular Atrophy (SMA) patient outside the US

This marks a significant advancement in gene therapy, as this patient is the second adult SMA patient worldwide to be treated with Novartis' Itvisma as independently verified by the manufacturer Novartis